TrialNature medicine2026

Gotistobart or docetaxel in metastatic squamous non-small cell lung cancer: stage 1 of the randomized phase 3 PRESERVE-003 trial.

Byoung Chul Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.